Elon Musk’s Brain-Computer Company “Neuralink” Receives FDA Approval to Launch Human Clinical Trial

May 26, 2023

806

Elon Musk’s brain-implant company Neuralink announced on Thursday that it has been granted official approval from the U.S. Food and Drug Administration (FDA) to launch its first-in-human clinical study.

“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!” Neuralink wrote on Twitter.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” it added.

TRUTH LIVES on at https://sgtreport.tv/

The company said recruitment is not yet open for the clinical trial. However, anyone interested to participate in the clinical trial can register their information on Neuralink’s patient registry.

According to the website, “anyone within the United States who is at least 18 years old and the age of majority in their state, who is able to consent, and who has quadriplegia, paraplegia, vision loss, hearing loss, and/or the inability to speak, is invited to participate in the Patient Registry.”

Read: Dr. Peter McCullough On “The Holy Grail Of COVID-19 Vaccine Detoxification”

Adding, “If you participate in the Patient Registry and we determine that you meet preliminary eligibility for future clinical trials, we may contact you to inform you of these trials once they become available.”

The goal of Neuralink is to develop a brain-machine interface technology, often referred to as a neural lace, that establishes a direct connection between the human brain and external computer.

Read More @ TheGatewayPundit.com

RELATED ARTICLESMORE FROM AUTHOR

Videos: Migrants Complain That New Yorkers Don’t Learn African Languages

Conspiracy Tik-Toker Kyle Marisa DEAD in Suspicious Circumstances! Was she Exposing too much?

Texas Is Being Turned Into a Woke Democrat State

RELATED ARTICLES MORE FROM AUTHOR